Poliovirus vaccine inactivated
As of the edition of 20 October 2026, Poliovirus vaccine inactivated is a vaccine component: marketed, first approved in 2000 (US); US protection ended in 2012.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 2000
- Kind
- Vaccine component
- Brand name
- Ipol
- First approved
- 4 February 2000 (US)
- Approvals on record
- 4 in 1 region
- Holder of the most recent approval
- Sanofi; 2 holders in all
- Registered trials
- 7, 0 stopped early
- Disease areas
- Infections; Nervous system; Lungs and airways; Cancer; Digestive system; Skin and connective tissue
US protection
US protection ended in 2012.
US protection ended in 2012, computed as 12 years from the first US licence because FDA publishes no date for this product. The application that gives this date is held by Sanofi. The date is computed, not published.
This is the US only, and it is not the date generics or biosimilars can enter.
The exact date and the listings behind it
In the product2 listings count towards this date. The exact date and each listing are in the product.
See the exact date and the 2 listings behind itRequest access. Nothing is shown until you do.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 1 | 1 | 0 | 1 | 0 |
| Phase 2 | 3 | 3 | 0 | 0 |
| Phase 3 | 2 | 2 | 0 | 0 |
| Phase 4 | 1 | 1 | 0 | 0 |
| All trials | 7 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Sanofi | Applicant, Earlier holder and Lead sponsor of trials | 2000 to now |